Castells A, Salmerón J M, Navasa M, Rimola A, Saló J, Andreu H, Mas A, Rodés J
Liver Unit, Hospital Clínic i Provincial, University of Barcelona, Catalunya, Spain.
Gastroenterology. 1993 Aug;105(2):532-8. doi: 10.1016/0016-5085(93)90731-q.
Liver transplantation has emerged as the most important advance in the therapy of acute liver failure. To assess the applicability of liver transplantation in this setting, the outcome of 62 patients with acute liver failure consecutively admitted to hospital was analyzed.
Criteria for indicating liver transplantation were grade III-IV hepatic encephalopathy or progression of encephalopathy following a transient improvement. In subfulminant cases, liver transplantation was also indicated when no improvement was observed after a 3-day period of conservative treatment.
Thirteen (21%) of the 62 patients never met criteria for transplant indication; all of them were discharged after receiving conventional therapy. Twenty-one (34%) patients with criteria for indicating liver transplantation could not receive the transplant because of either contraindications (17 patients; only 1 being discharged from hospital) or death before donor organ availability (4 patients). Finally, 28 (45%) patients received a liver transplant and 22 were discharged from hospital.
The applicability of liver transplantation in acute liver failure is relatively low. Considering the high survival rate (79%) obtained in the patients with transplantations and the poor survival rate (6%) observed in those who could not be transplanted, efforts should be made to increase liver transplant applicability to improve the prognosis in acute liver failure.
肝移植已成为急性肝衰竭治疗中最重要的进展。为评估肝移植在此情况下的适用性,对连续入院的62例急性肝衰竭患者的预后进行了分析。
肝移植指征为III-IV级肝性脑病或在短暂改善后脑病进展。在亚急性肝衰竭病例中,若经过3天的保守治疗后无改善,也可考虑肝移植。
62例患者中有13例(21%)从未达到移植指征标准;所有这些患者在接受常规治疗后均出院。21例(34%)符合肝移植指征标准的患者因禁忌证(17例;仅1例出院)或在获得供体器官前死亡(4例)而未能接受移植。最后,28例(45%)患者接受了肝移植,22例出院。
肝移植在急性肝衰竭中的适用性相对较低。鉴于接受移植患者的高生存率(79%)以及未接受移植患者的低生存率(6%),应努力提高肝移植的适用性,以改善急性肝衰竭的预后。